These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15939202)

  • 81. Current Topics in Postnatal Behavioral Testing.
    Henck JW; Elayan I; Vorhees C; Fisher JE; Morford LL
    Int J Toxicol; 2016 Sep; 35(5):499-520. PubMed ID: 27381384
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Assessing laboratory evidence for neoplastic activity.
    Mantel N
    Biometrics; 1980 Sep; 36(3):381-99. PubMed ID: 7213907
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The IPCS collaborative study on neurobehavioral screening methods.
    Moser VC; Becking GC; MacPhail RC; Kulig BM
    Fundam Appl Toxicol; 1997 Feb; 35(2):143-51. PubMed ID: 9038235
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Neurotoxic chemical exposure scenarios and suggested solutions.
    Schaumberg HH; Arezzo J; Otto DA; Eckerman DA
    Neurobehav Toxicol Teratol; 1985; 7(4):351-3. PubMed ID: 4058644
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A survey of frameworks for best practices in weight-of-evidence analyses.
    Rhomberg LR; Goodman JE; Bailey LA; Prueitt RL; Beck NB; Bevan C; Honeycutt M; Kaminski NE; Paoli G; Pottenger LH; Scherer RW; Wise KC; Becker RA
    Crit Rev Toxicol; 2013 Oct; 43(9):753-84. PubMed ID: 24040995
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Proceedings of a workshop on DNA adducts: biological significance and applications to risk assessment Washington, DC, April 13-14, 2004.
    Sander M; Cadet J; Casciano DA; Galloway SM; Marnett LJ; Novak RF; Pettit SD; Preston RJ; Skare JA; Williams GM; Van Houten B; Gollapudi BB
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):1-20. PubMed ID: 16164957
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Risk assessment strategies for neuroprotective agents.
    Slikker W; Gaylor DW
    Ann N Y Acad Sci; 1995 Sep; 765():198-208; discussion 209. PubMed ID: 7486606
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The measurement and integration of behavioral variables: aggregation and complexity as important issues.
    Ossenkopp KP; Mazmanian DS
    Neurobehav Toxicol Teratol; 1985; 7(1):95-100. PubMed ID: 4000372
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Neurobehavioral testing in human risk assessment.
    Rohlman DS; Lucchini R; Anger WK; Bellinger DC; van Thriel C
    Neurotoxicology; 2008 May; 29(3):556-67. PubMed ID: 18539229
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Neurobehavioral aspects of developmental toxicity testing.
    Ulbrich B; Palmer AK
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):407-12. PubMed ID: 9182049
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Behavioral toxicology: new experimental approaches. The first joint International Union of Toxicology and Italian Society of Toxicology symposium on behavioral toxicology. Bari, Italy, October 3, 1986. Proceedings.
    Neurotoxicol Teratol; 1987; 9(2):143-92. PubMed ID: 3657749
    [No Abstract]   [Full Text] [Related]  

  • 92. Accelerating the development of 21st-century toxicology: outcome of a Human Toxicology Project Consortium workshop.
    Stephens ML; Barrow C; Andersen ME; Boekelheide K; Carmichael PL; Holsapple MP; Lafranconi M
    Toxicol Sci; 2012 Feb; 125(2):327-34. PubMed ID: 21948868
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Proceedings of a workshop to address animal methods bias in scientific publishing.
    Krebs CE; Camp C; Constantino H; Courtot L; Kavanagh O; Leite SB; Madden J; Paini A; Poojary B; Tripodi IJ; Trunnell ER
    ALTEX; 2023; 40(4):677-688. PubMed ID: 36317507
    [TBL] [Abstract][Full Text] [Related]  

  • 94. New directions in assessment for students with disabilities.
    Telzrow CF; McNamara K
    Work; 2001; 17(2):105-116. PubMed ID: 12441609
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Reconsideration of the WHO NCTB strategy and test selection.
    Anger WK
    Neurotoxicology; 2014 Dec; 45():224-31. PubMed ID: 25172409
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Problems associated with the study of cellular oscillations.
    Gilbert DA; Ferreira GM
    Cell Biol Int; 2000; 24(8):501-14. PubMed ID: 10924224
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Workshop on neurobehavioral methods in safety assessment of chemicals and drugs. Düsseldorf, F.R.G., December 16-19, 1985.
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1987 Oct; 185(1-2):1-71. PubMed ID: 3124370
    [No Abstract]   [Full Text] [Related]  

  • 98. Behavioral strategies for the evaluation of new pharmacotherapies for drug abuse treatment.
    Mello NK
    NIDA Res Monogr; 1992; 119():150-4. PubMed ID: 1435971
    [No Abstract]   [Full Text] [Related]  

  • 99. The intersection of risk assessment and neurobehavioral toxicity.
    Weiss B; Elsner J
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):173-7. PubMed ID: 8860320
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Proceedings of a symposium entitled Environmental Neurotoxicology--Assessment of Nervous System and Behavioral Dysfunction. Dusseldorf, March 29-31, 1982.
    Neurobehav Toxicol Teratol; 1982; 4(6):595-746. PubMed ID: 7170016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.